[iNtRON] Files U.S. Patent for Three Novel Endolysin-Based Drug Candidates Targeting Gram-Negative Bacteria
- Written by PR Newswire
- Gram-negative bacterial infections are becoming an increasingly serious global health issue
- U.S. patent applications filed for three novel drug candidates: PKL200, TSL2200, and EAL2200
- Continued diversification of business initiatives to address Gram-negative bacterial threats
BOSTON and SEOUL, South Korea, July 2, 2025 /PRNewswire/ -- More than...
